SUZANNE GAZDA M.D.
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact

MS in the NEWS

Understanding the implications in cognitive-dominant MS.

4/10/2021

2 Comments

 
Picture
While multiple sclerosis (MS) is often considered a disease that presents with impaired motor function, a recent presentation at the ACTRIMS 2021 virtual conference shared an analysis of two ongoing studies and the degree to which signs of cognitive dysfunction in cases of relapsing-remitting MS (RMSS) may precede any motor issues.

Read More
2 Comments

What a NeuroQuant® image can tell us about MS.

4/5/2021

1 Comment

 

And why we should include it in our assessment protocols. 

Picture
In considering how we can best gauge brain health or the progression of a known disorder, practitioners do have many tools we can employ to get a truly comprehensive perspective to determine the most appropriate therapy.

Read More
1 Comment

Is there support for the efficacy of memantine in MS?

4/1/2021

1 Comment

 
In a recent review, scientists looked at findings from several clinical trials that evaluated whether memantine, a glutamate-signaling suppressor, might prove to have any efficacy when used in patients suffering with multiple sclerosis (MS).

A bit of background…
As an abundant chemical messenger in the brain, glutamate plays a vital role in the functions of learning and memory, but in large amounts can impose significant negative impacts. ​
Picture

Read More
1 Comment

The relationship between glutamate and GABA.

4/1/2021

1 Comment

 
How can we reduce excess glutamate? 

As the most abundant neurotransmitter in our nervous system, glutamate plays a critical role in normal brain functioning and requires that its levels must be well regulated in order to avoid either an excess or dearth of this important chemical messenger. 
Picture

Read More
1 Comment

    Author

    Suzanne Gazda M.D.

    Archives

    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    December 2021
    May 2021
    April 2021
    March 2021
    January 2021

    Categories

    All

    RSS Feed

SITE MAP

HOME
MEET DR. GAZDA
OUR PRACTICE
INTEGRATIVE MEDICINE
OUR APPROACH
CONDITIONS WE TREAT
TREATMENT PROTOCOLS
PATIENT STORIES
FAQ
POLICIES & RATES
BLOG
SCIENTIFICALLY SPEAKING
MEDICAL RESOURCES
JOURNAL ARTICLES
LINKS
BECOME A PATIENT
CONTACT
NEWS
PRODUCT RECOMMENDATIONS

Location

San Antonio, Texas

Telephone

210-692-1245
Fax
210-692-9311

Email

baguillon@nisatx.com
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact